Abstract:Psychotherapy with the use of psychedelic substances, including psilocybin, lysergic acid diethylamide (LSD), ketamine, and 3,4-methylenedioxymethamphetamine (MDMA), has demonstrated promise in treatment of post-traumatic stress disorder (PTSD), anxiety, addiction, and treatment-resistant depression. Psychedelic-assisted psychotherapy (PP) represents a unique psychopharmacological model that leverages the profound effects of the psychedelic experience. That experience is characterized by strong dependency on two key factors: participant mindset and the therapeutic environment. As such, therapeutic models that utilize psychedelics reflect the need for careful design that promotes an open, flexible, trusting mindset and a supportive setting. To meet this need, the PP model is increasingly supplemented by auxiliary methods, including meditation, relaxation, visualization or spiritual practices. We suggest virtual reality (VR) as a full-spectrum tool able to capitalize on and catalyze the innately therapeutic aspects of the psychedelic experience, such as detachment from familiar reality, alteration of self-experience, augmentation of sensory perception and induction of mystical-type experiences. This is facilitated by VR's evidenced capacity to: aid relaxation and reduce anxiety; buffer from external stimuli; promote a mindful presence; train the mind to achieve altered states of consciousness (ASC); evoke mystical states; enhance therapeutic alliance and encourage self-efficacy. While these unique VR features appear promising, VR's potential role in PP remains speculative due to lack of empirical evidence on the combined use of VR and PP. Given the increased commercial interest in this synergy there is an urgent need to evaluate this approach. We suggest specific VR models and their role within PP protocols to inspire future direction in scientific research, and provide a list of potential disadvantages, side effects and limitations that need to be carefully considered. These include sensory overstimulation, cyber-sickness, triggering memories of past traumatic events as well as distracting from the inner experience or strongly influencing its contents. A balanced, evidence-based approach may provide continuity across all phases of treatment, support transition into and out of an ASC, deepen acute ASC experiences including mystical states and enrich the psychotherapeutic process of integration. We conclude that the potential application of VR in modulating psychedelic-assisted psychotherapy demands further exploration and an evidence-based approach to both design and implementation.

Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?

Clarifying the ethical landscape of psychedelic-assisted psychotherapy

Psilocybin, moralization and psychotherapy: a coping review and a case report

Psychedelic research at a crossroads

How to Make Psychedelic-Assisted Therapy Safer

An Integrated theory of false insights and beliefs under psychedelics

Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money

Are Psychedelic Experiences Transformative? Can We Consent to Them?

Psychedelic-assisted psychotherapy: where is the psychotherapy research?

Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications

Do Psychedelic Trips Open the Door to Messages from God, Spirits, Transcendent Realities, or the Devil? Links with Attitudes About Psychedelics, Opinions About Legalization, and Interest in Personal Use

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines

Attitudes of European psychiatrists on psychedelics: a qualitative study

Is Poorly Assisted Psilocybin Treatment an Increasing Risk?

Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review

What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes

Psychiatric risks for worsened mental health after psychedelic use

The cyclical revival of psychedelics in psychiatric treatment

Psychedelics and Other Psychoplastogens for Treating Mental Illness

History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers

Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy